| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
SELPLG, also known as P-selectin glycoprotein ligand-1 (PSGL-1) or CD162, serves as a critical adhesion molecule that mediates the initial tethering and rolling of leukocytes along activated endothelium during inflammatory responses. This interaction between PSGL-1 and selectins represents a fundamental step in immune cell trafficking, making it a key target for researchers investigating inflammation, leukocyte recruitment, and immunological disorders.
This recombinant monoclonal antibody, clone 18F4, offers the reproducibility and consistency that demanding immunology research requires. Because it is produced using recombinant technology with a defined sequence, you can expect uniform performance across experiments and over time, eliminating the lot-to-lot variability that can complicate long-term studies or multi-site collaborations. The human IgG4 isotype format and affinity-chromatography purification ensure high specificity for your target.
Validated for both Western blot and ELISA applications, this antibody provides flexibility across your experimental workflow. Western blot analysis in MCF-7 whole cell lysate demonstrates clean detection of SELPLG at the predicted molecular weight of 43 kDa, confirming reliable target recognition. Working dilutions between 1:500 and 1:2000 for Western blot allow you to optimize signal intensity based on your specific sample conditions and detection system.
The antibody is supplied in a liquid format containing 50% glycerol in PBS with 0.03% Proclin 300 as preservative, ready for immediate use in your experiments. For researchers exploring selectin-mediated adhesion, inflammatory cell recruitment, or CD162 biology in human systems, this recombinant antibody delivers the technical performance and experimental confidence needed to advance your immunology research.
Email: support@cusabio.com
Distributors Worldwide